GlassScriptPhysician profile
James M Harshman
NPI 1902896871
$3,740.91
in general payments reported to CMS, 2019-2025
32 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,069 · 2020: $848 · 2021: $1,413 · 2022: $410.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $1,262.07 | 2019-2022 | |
| Antares Pharma, INC. | $321.80 | 2019-2022 | |
| Myriad Genetic Laboratories, INC. | $293.01 | 2020-2022 | |
| Tolmar Pharmaceuticals, INC. | $236.84 | 2019-2022 | |
| Abbvie INC. | $204.54 | 2019-2022 | |
| Boston Scientific Corporation | $171.01 | 2019-2022 | |
| Neotract INC. | $135.14 | 2019-2020 | |
| Pfizer INC. | $123.18 | 2019-2022 | |
| Myovant Sciences INC. | $103.05 | 2021-2022 | |
| Coloplast Corp | $101.60 | 2019-2022 | |
| Rochester Medical Corporation | $74.08 | 2020-2021 | |
| Clarus Therapeutics INC. | $71.10 | 2021 | |
| Amgen INC. | $67.01 | 2019-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $62.15 | 2019-2021 | |
| 180 Medical, INC. | $55.31 | 2019-2020 |
Show all 32 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic USA, INC. | $53.94 | 2020 | |
| Janssen Biotech, INC. | $48.09 | 2019 | |
| Axonics, INC. | $47.90 | 2021 | |
| Blue Earth Diagnostics | $45.55 | 2019-2021 | |
| Zyla Life Sciences, INC. | $39.05 | 2019 | |
| Therapeuticsmd, INC. | $28.35 | 2019 | |
| Urovant Sciences INC | $26.57 | 2021 | |
| Dendreon Pharmaceuticals LLC | $24.75 | 2019 | |
| Convatec INC. | $21.85 | 2021 | |
| Procept Biorobotics Corporation | $20.73 | 2022 | |
| Sun Pharmaceutical Industries INC. | $19.16 | 2022 | |
| Medtronic, INC. | $15.89 | 2021 | |
| Medline Industries LP | $15.73 | 2022 | |
| Duchesnay USA Incorporated | $14.57 | 2019 | |
| Photocure INC | $13.49 | 2020 | |
| Merck Sharp & Dohme LLC | $12.31 | 2019 | |
| Avadel Specialty Pharmaceuticals, LLC | $11.09 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Harshman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.